David Alberts
Hoofd Techniek/Wetenschap/O&O bij Omnitura Therapeutics, Inc.
Actieve functies van David Alberts
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Omnitura Therapeutics, Inc.
 Omnitura Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Omnitura Therapeutics, Inc. is a biopharmaceutical company engaged in the commercialization of Multifunctional Multitargeted pharmaceuticals for oncology, a new class of therapies that is design to address the fundamentally complex and heterogeneous nature of cancer. The firm's product Aneustat, is a non-toxic, orally delivered, multivalent I-O drug candidate design to intercept, treat, and prevent cancer. The company was founded by James Dao and Jeffrey Dao in 2001 and is headquartered in Burlingame, CA. | Directeur/Bestuurslid | - | - |
| Hoofd Techniek/Wetenschap/O&O | - | - | |
| University of Arizona | Directeur/Bestuurslid | 18-09-2009 | - |
Loopbaan van David Alberts
Statistieken
Internationaal
| Verenigde Staten | 3 |
Operationeel
| Director/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Sectoraal
| Health Technology | 2 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Bedrijven in privébezit | 1 |
|---|---|
Omnitura Therapeutics, Inc.
Omnitura Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Omnitura Therapeutics, Inc. is a biopharmaceutical company engaged in the commercialization of Multifunctional Multitargeted pharmaceuticals for oncology, a new class of therapies that is design to address the fundamentally complex and heterogeneous nature of cancer. The firm's product Aneustat, is a non-toxic, orally delivered, multivalent I-O drug candidate design to intercept, treat, and prevent cancer. The company was founded by James Dao and Jeffrey Dao in 2001 and is headquartered in Burlingame, CA. | Health Technology |
- Beurs
- Insiders
- David Alberts
- Ervaring
